Collectively, these findings suggest that RTKis, particularly the HER2 inhibitors AFA and NER, are highly potent on established AR-positive PCa cell lines, and that cells resistant to these treatments after 1–5 days express proportionally greater levels of AR. Here, AR is linked to posterior cortical atrophy.